Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Dynamics Corporation (GD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

General Dynamics CorporationTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

General Dynamics Corporation vs Vir Biotechnology Inc. Common Stock — how do they compare? General Dynamics Corporation trades at $338.85 (market cap $89.94B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: General Dynamics Corporation is far larger — about 50× Vir Biotechnology Inc. Common Stock's market cap, and General Dynamics Corporation pays a 1.91% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Dynamics Corporation for 86 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

GDVIR
Market Cap
$89.94B$1.80B
Volume
1,284,0201,782,836
Sector
IndustrialsHealth
52-Week High
$395.97$11.78
52-Week Low
$312.53$5.12
Typical Hold Time
86 Days0 Days
Enterprise Value
$95.08B$1.36B
Dividend Yield
1.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Dynamics Corporation

General Dynamics (GD) trades at $334.66, down 0.24% with bearish technical signals despite strong fundamentals. The defense contractor shows robust revenue growth, increasing from $47.7B in 2024 to $52.5B in 2025, with consistent earnings beats. Analyst consensus remains bullish with a $414.57 price target, supported by strong Pentagon spending and dividend stability.

GD presents a compelling value opportunity with reasonable valuation multiples (P/E 20.27) and strong cash flow generation. Key risks include defense budget volatility and execution challenges, but the company's record backlog and dividend champion status provide downside protection. Upside potential exists if technical resistance at $337 is breached.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GD
0% Buy100% Sell
Avg holding period · 86 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About General Dynamics Corporation

General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.

Read more on GD →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →